BAYER AG S/ADR (BAYRY) analyst actions
Rating and price-target actions on BAYRY in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the BAYRY overview →
1 measured BAYRY analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| BAYER INITIATES PHASE II STUDY OF INVESTIGATIONAL GIRK4 INHIBITOR IN PATIENTS WITH ATRIAL FIBRILLATION | Press release | +0.21% | +0.42% |
Keep exploring
More BAYRY: earnings → · SEC filings → · BAYRY overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Mesoblast Limited - American Depositary Shares (MESO) | 108 | -0.47% | 42% |
| WELLNESS CENTER USA INC (WCUI) | 108 | 0.00% | 24% |
| Aileron Therapeutics, Inc. (ALRN) | 105 | 0.00% | 35% |
| CBA FLORIDA (CBAI) | 105 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.